Bill Status of SB 1842   102nd General Assembly

Short Description:  CONTROLLED SUBSTANCES-OPIOIDS

Senate Sponsors
Sen. Mattie Hunter, Rachelle Crowe and Karina Villa

House Sponsors
(Rep. La Shawn K. Ford)


Last Action  View All Actions

DateChamber Action
  8/20/2021SenatePublic Act . . . . . . . . . 102-0527

Statutes Amended In Order of Appearance
720 ILCS 570/314.5
720 ILCS 570/316

Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that when a person has been identified as having 5 (rather than 3) or more prescribers or 5 (rather than 3) or more pharmacies, or both, that do not utilize a common electronic file for controlled substances within the course of a 6-month (rather than continuous 30-day) period, the Prescription Monitoring Program may issue an unsolicited report to the prescribers, dispensers, and their designees informing them of the potential medication shopping. Provides that specified requirements also apply to opioid treatment programs that are licensed or certified by the Department of Human Services' Division of Substance Use Prevention and Recovery and are authorized by the federal Drug Enforcement Administration to prescribe Schedule II, III, IV, or V controlled substances for the treatment of opioid use disorders. Requires opioid treatment programs to attempt to obtain written patient consent, document attempts to obtain the written consent, and not transmit information without patient consent. Provides that the documentation obtained shall not be utilized for law enforcement purposes. Provides that treatment of a patient shall not be conditioned upon his or her written consent. Makes other changes. Effective immediately.

Actions 
DateChamber Action
  2/26/2021SenateFiled with Secretary by Sen. Mattie Hunter
  2/26/2021SenateFirst Reading
  2/26/2021SenateReferred to Assignments
  3/16/2021SenateAssigned to Healthcare Access and Availability
  3/24/2021SenateDo Pass Healthcare Access and Availability; 007-000-000
  3/24/2021SenatePlaced on Calendar Order of 2nd Reading March 25, 2021
  4/21/2021SenateSecond Reading
  4/21/2021SenatePlaced on Calendar Order of 3rd Reading April 22, 2021
  4/22/2021SenateThird Reading - Passed; 057-000-000
  4/23/2021HouseArrived in House
  4/23/2021HouseChief House Sponsor Rep. La Shawn K. Ford
  4/23/2021HouseFirst Reading
  4/23/2021HouseReferred to Rules Committee
  4/23/2021SenateAdded as Co-Sponsor Sen. Rachelle Crowe
  5/3/2021SenateAdded as Co-Sponsor Sen. Karina Villa
  5/4/2021HouseAssigned to Prescription Drug Affordability & Accessibility Committee
  5/12/2021HouseDo Pass / Consent Calendar Prescription Drug Affordability & Accessibility Committee; 017-000-000
  5/13/2021HousePlaced on Calendar 2nd Reading - Consent Calendar
  5/24/2021HouseSecond Reading - Consent Calendar
  5/24/2021HouseHeld on Calendar Order of Second Reading - Consent Calendar
  5/25/2021HousePlaced on Calendar Order of 3rd Reading - Consent Calendar
  5/26/2021HouseThird Reading - Consent Calendar - First Day
  5/27/2021HouseThird Reading - Consent Calendar - Passed 116-000-000
  5/27/2021SenatePassed Both Houses
  6/25/2021SenateSent to the Governor
  8/20/2021SenateGovernor Approved
  8/20/2021SenateEffective Date August 20, 2021
  8/20/2021SenatePublic Act . . . . . . . . . 102-0527

Back To Top